MedTrace Logo

Multi-Omic Profiling of a Zinc-Biofortified Maize Intervention in Guatemalan Mothers and Children

NCT07585318 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-05-22

No results posted yet for this study

Summary

A trial evaluating the systemic and ecological impact of zinc-biofortified maize consumption on cellular zinc status, inflammatory biomarkers, and gut microbiota composition in a cohort of Guatemalan mothers and children.

Conditions

  • Zinc Deficiency
  • Mother and Child Malnutrition

Interventions

OTHER

F3 Biofortified Maize

Daily consumption of zinc-biofortified maize (F3) for up to 10 months.

OTHER

Conventional Maize

Daily consumption of conventional maize for the duration of the study.

Sponsors & Collaborators

  • Institute of Nutrition of Central America and Panama

    lead OTHER

Principal Investigators

  • Elad Tako, PhD · Cornell University

  • Manolo Mazariegos · Institute of Nutrition of Central America and Panama

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
24 Months
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • Guatemala

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07585318 on ClinicalTrials.gov